MapLight Therapeutics, Inc. (MPLT)

MapLight Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	64.15	38.25	79.77	27.67
Short-Term Investments	163.02	70.54	-	-
Cash & Short-Term Investments	227.17	108.8	79.77	27.67
Cash Growth	26.34%	36.39%	188.34%	-
Prepaid Expenses	18.14	5.81	3.84	4.37
Total Current Assets	245.31	114.6	83.6	32.03
Property, Plant & Equipment	6.57	7.56	6.59	7.12
Long-Term Investments	-	11.38	0.99	-
Other Long-Term Assets	5.35	3.37	0.23	0.23
Total Assets	257.22	136.92	91.41	39.39
Accounts Payable	2.45	1.91	3.25	3.6
Accrued Expenses	14.05	9.99	6.76	2.79
Current Portion of Leases	0.86	0.78	0.5	0.35
Current Unearned Revenue	1.21	3.24	4.2	5.86
Total Current Liabilities	18.56	15.92	14.7	12.6
Long-Term Leases	5.14	5.8	5.43	5.92
Total Liabilities	23.71	21.72	20.13	18.52
Additional Paid-In Capital	6.75	5.58	4.2	3.12
Retained Earnings	-280.97	-199.37	-121.79	-66.08
Comprehensive Income & Other	0.05	0.16	-	-
Total Common Equity	-274.18	-193.63	-117.59	-62.96
Shareholders' Equity	233.52	115.2	71.28	20.87
Total Liabilities & Equity	257.22	136.92	91.41	39.39
Total Debt	6.01	6.58	5.92	6.27
Net Cash (Debt)	221.16	102.22	73.85	21.39
Net Cash Growth	27.10%	38.42%	245.17%	-
Net Cash Per Share	287.61	138.84	111.94	38.41
Filing Date Shares Outstanding	608.9	0.76	0.67	0.56
Total Common Shares Outstanding	608.9	0.76	0.67	0.56
Working Capital	226.74	98.68	68.91	19.44
Book Value Per Share	-0.45	-254.32	-176.19	-113.03
Tangible Book Value	-274.18	-193.63	-117.59	-62.96
Tangible Book Value Per Share	-0.45	-254.32	-176.19	-113.03
Machinery	3.32	3.28	2.77	2.22
Leasehold Improvements	-	0.01	0.01	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q